Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Summit Therapeu ADR (SMMT)
Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,151,180
  • Shares Outstanding, K 697,685
  • Annual Sales, $ 710 K
  • Annual Income, $ -78,780 K
  • 60-Month Beta -1.01
  • Price/Sales 1,613.09
  • Price/Cash Flow N/A
  • Price/Book 2.72
Trade SMMT with:

Options Overview Details

View History
  • Implied Volatility 88.96% ( -23.94%)
  • Historical Volatility 131.88%
  • IV Percentile 24%
  • IV Rank 5.11%
  • IV High 1,399.59% on 05/09/22
  • IV Low 18.41% on 03/14/23
  • Put/Call Vol Ratio 0.19
  • Today's Volume 618
  • Volume Avg (30-Day) 2,408
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 40,399
  • Open Int (30-Day) 52,335

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2500 +33.60%
on 03/07/23
2.2800 -26.75%
on 02/23/23
-0.6200 (-27.07%)
since 02/22/23
3-Month
1.2500 +33.60%
on 03/07/23
5.7800 -71.11%
on 01/04/23
-2.1700 (-56.51%)
since 12/22/22
52-Week
0.6600 +153.03%
on 12/02/22
5.7800 -71.11%
on 01/04/23
-1.7800 (-51.59%)
since 03/22/22

Most Recent Stories

More News
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Summit Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Summit Therapeutics Inc. (“Summit” or “the Company”) (NASDAQ:...

SMMT : 1.6700 (+1.21%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Summit Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Summit Therapeutics Inc. (“Summit” or “the Company”) (NASDAQ:...

SMMT : 1.6700 (+1.21%)
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the fourth quarter and year ended December...

SMMT : 1.6700 (+1.21%)
EPIX : 2.97 (-2.62%)
PBYI : 2.34 (-6.77%)
Summit Therapeutics Closes Fully-Subscribed $500 Million Rights Offering

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced the successful closing of its fully-subscribed $500 million rights offering.

SMMT : 1.6700 (+1.21%)
Summit Therapeutics’ Rights Offering Nearing Expiration Date

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it is nearing the previously-announced expiration date for its rights offering of 5:00 pm Eastern...

SMMT : 1.6700 (+1.21%)
Summit Therapeutics Announces Timing for Rights Offering for Up to $500 Million

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that the Company’s Board of Directors has set the record date for the Company’s previously announced rights...

SMMT : 1.6700 (+1.21%)
Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that we have completed the closing of our previously announced definitive agreement with Akeso Inc....

SMMT : 1.6700 (+1.21%)
Summit Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it will participate in and present at the 41 st Annual J.P. Morgan Healthcare Conference on...

SMMT : 1.6700 (+1.21%)
Why Summit Therapeutics Shares Soared This Week

The clinical-stage biopharma stock has been rising all year.

SMMT : 1.6700 (+1.21%)
Why Summit Therapeutics Stock Is Skyrocketing This Week

The company announced an important licensing deal.

SMMT : 1.6700 (+1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 1.9267
2nd Resistance Point 1.8633
1st Resistance Point 1.7667
Last Price 1.6700
1st Support Level 1.6067
2nd Support Level 1.5433
3rd Support Level 1.4467

See More

52-Week High 5.7800
Fibonacci 61.8% 3.8242
Fibonacci 50% 3.2200
Fibonacci 38.2% 2.6158
Last Price 1.6700
52-Week Low 0.6600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar